Step Number and Aerobic Minute Exercise Prescription and Progression in Stroke: A Roadmap.


Journal

Neurorehabilitation and neural repair
ISSN: 1552-6844
Titre abrégé: Neurorehabil Neural Repair
Pays: United States
ID NLM: 100892086

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 25 12 2021
medline: 22 2 2022
entrez: 24 12 2021
Statut: ppublish

Résumé

While higher therapeutic intensity improves motor recovery after stroke, translating findings from successful studies is challenging without clear exercise intensity targets. We show in the DOSE trial We modeled data from this successful higher intensity multi-site RCT to develop targets for prescribing and progressing exercise for varying levels of walking impairment after stroke. In twenty-five individuals in inpatient rehabilitation, twenty sessions were monitored for a total of 500 one-hour physical therapy sessions. For the 500 sessions, step number and aerobic minute progression were modeled using linear mixed effects regression. Using formulas from the linear mixed effects regression, targets were calculated. The model for step number included session number and baseline walking speed, and for aerobic minutes, session number and age. For steps, there was an increase of 73 steps per session. With baseline walking speed, for every 0.1 m/s increase, a corresponding increase of 302 steps was predicted. For aerobic minutes, there was an increase of .56 minutes of aerobic activity (ie, 34 seconds) per session. For every year increase in age, a decrease of .39 minutes (ie, 23 seconds) was predicted. Using data associated with better walking outcomes, we provide step number and aerobic minute targets that future studies can cross-validate. As walking speed and age are collected at admission, these models allow for uptake of routine measurement of therapeutic intensity.Registration: www.clinicaltrials.gov; NCT01915368.

Sections du résumé

BACKGROUND
While higher therapeutic intensity improves motor recovery after stroke, translating findings from successful studies is challenging without clear exercise intensity targets. We show in the DOSE trial
OBJECTIVE
We modeled data from this successful higher intensity multi-site RCT to develop targets for prescribing and progressing exercise for varying levels of walking impairment after stroke.
METHODS
In twenty-five individuals in inpatient rehabilitation, twenty sessions were monitored for a total of 500 one-hour physical therapy sessions. For the 500 sessions, step number and aerobic minute progression were modeled using linear mixed effects regression. Using formulas from the linear mixed effects regression, targets were calculated.
RESULTS
The model for step number included session number and baseline walking speed, and for aerobic minutes, session number and age. For steps, there was an increase of 73 steps per session. With baseline walking speed, for every 0.1 m/s increase, a corresponding increase of 302 steps was predicted. For aerobic minutes, there was an increase of .56 minutes of aerobic activity (ie, 34 seconds) per session. For every year increase in age, a decrease of .39 minutes (ie, 23 seconds) was predicted.
CONCLUSIONS
Using data associated with better walking outcomes, we provide step number and aerobic minute targets that future studies can cross-validate. As walking speed and age are collected at admission, these models allow for uptake of routine measurement of therapeutic intensity.Registration: www.clinicaltrials.gov; NCT01915368.

Identifiants

pubmed: 34949129
doi: 10.1177/15459683211062894
pmc: PMC8796151
doi:

Banques de données

ClinicalTrials.gov
['NCT01915368']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-102

Subventions

Organisme : CIHR
ID : FDN 143340
Pays : Canada

Références

Gait Posture. 2012 Mar;35(3):395-9
pubmed: 22119886
Curr Neurol Neurosci Rep. 2015;15(2):519
pubmed: 25475494
Stroke. 2020 Sep;51(9):2639-2648
pubmed: 32811378
Phys Ther Res. 2019 May 20;22(1):17-25
pubmed: 31289708
J Rehabil Med. 2012 Oct;44(10):824-9
pubmed: 22878434
Physiother Theory Pract. 2016 Aug;32(6):452-460
pubmed: 27459027
Stroke. 2007 Jul;38(7):2096-100
pubmed: 17510461
Front Neurol. 2019 Nov 15;10:1187
pubmed: 31803129
Int J Stroke. 2019 Jan;14(1):80-86
pubmed: 30010509
Stroke. 2017 Sep;48(9):2614-2617
pubmed: 28784922
Maturitas. 2019 May;123:32-36
pubmed: 31027674
Biomed Res Int. 2014;2014:925762
pubmed: 25045713
Arch Phys Med Rehabil. 2014 Aug;95(8):1547-55.e4
pubmed: 24755045
BMJ Open Sport Exerc Med. 2016 Apr 25;2(1):e000106
pubmed: 27900173

Auteurs

Sue Peters (S)

School of Physical Therapy, 6221University of Western Ontario, Ontario, Canada.

Tara Klassen (T)

Department of Physical Therapy, University of British Columbia, Vancouver, Canada.
Rehabilitation Research Program, 175184Vancouver Coastal Health Research Institute, Vancouver, Canada.

Amy Schneeberg (A)

Department of Physical Therapy, University of British Columbia, Vancouver, Canada.

Sean Dukelow (S)

Department of Clinical Neurosciences and Hotchkiss Brain Institute, 2129University of Calgary, Calgary, Canada.

Mark Bayley (M)

Brain and Spinal Cord Rehab program, Toronto Rehabilitation Institute - University Health Network, Toronto, Canada.

Michael Hill (M)

Department of Clinical Neurosciences and Hotchkiss Brain Institute, 2129University of Calgary, Calgary, Canada.

Sepideh Pooyania (S)

Division of Physical Medicine and Rehabilitation, 8664University of Manitoba, Winnipeg, USA.

Jennifer Yao (J)

Vancouver Coastal Health, 103221G F Strong Rehabilitation Hospital, Vancouver, Canada.

Janice Eng (J)

Department of Physical Therapy, University of British Columbia, Vancouver, Canada.
Rehabilitation Research Program, 175184Vancouver Coastal Health Research Institute, Vancouver, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH